News
BGM
0.3446
+6.29%
0.0204
BGM Group’s Zhang Lin files initial beneficial ownership statement as director
PUBT · 1d ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 1d ago
Weekly Report: what happened at BGM last week (0406-0410)?
Weekly Report · 1d ago
Weekly Report: what happened at BGM last week (0330-0403)?
Weekly Report · 04/06 10:17
Weekly Report: what happened at BGM last week (0323-0327)?
Weekly Report · 03/30 10:17
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 03/23 12:05
Weekly Report: what happened at BGM last week (0316-0320)?
Weekly Report · 03/23 10:13
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 03/20 21:05
Weekly Report: what happened at BGM last week (0309-0313)?
Weekly Report · 03/16 10:13
Weekly Report: what happened at BGM last week (0302-0306)?
Weekly Report · 03/09 10:13
Weekly Report: what happened at BGM last week (0223-0227)?
Weekly Report · 03/02 10:12
BGM Group receives noncompliance letter from Nasdaq
TipRanks · 02/26 22:30
BGM Group Receives Nasdaq Noncompliance Notice, Gets 60 Days To Regain Compliance
Benzinga · 02/26 21:45
BGM Group receives Nasdaq notice over late annual report filing
Seeking Alpha · 02/26 21:32
BGM GROUP LTD. RECEIVES NASDAQ NOTICE RELATED TO LATE FILING OF FORM 20-F
Reuters · 02/26 21:15
Weekly Report: what happened at BGM last week (0216-0220)?
Weekly Report · 02/23 10:12
Weekly Report: what happened at BGM last week (0209-0213)?
Weekly Report · 02/16 10:12
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 02/10 21:05
Weekly Report: what happened at BGM last week (0202-0206)?
Weekly Report · 02/09 10:13
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 02/04 17:05
More
Webull provides a variety of real-time BGM stock news. You can receive the latest news about BGM Group through multiple platforms. This information may help you make smarter investment decisions.
About BGM
BGM Group Ltd, formerly Qilian International Holding Group Ltd, is a company mainly engaged in the development, manufacture, marketing and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives (TCMD) product, heparin product, sausage casings and fertilizers. The Company operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. The Company's main brand is Qilian Shan. The Company principally operates its businesses within the domestic market.